Abbott Laboratories Liabilities 2024

Abbott Laboratories Aktienanalyse

What does Abbott Laboratories do?

Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Abbott Laboratories's Liabilities

Abbott Laboratories's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Abbott Laboratories's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Abbott Laboratories's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Abbott Laboratories's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Abbott Laboratories’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Abbott Laboratories Stock

What is the level of liabilities of Abbott Laboratories this year?

Abbott Laboratories has a debt balance of 34.61 B USD this year.

What were the liabilities of Abbott Laboratories compared to the previous year?

The liabilities of Abbott Laboratories have increased by -8.32% dropped compared to the previous year.

What are the consequences of high debt for investors of Abbott Laboratories?

High liabilities can pose a risk for investors of Abbott Laboratories, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Abbott Laboratories?

Low liabilities mean that Abbott Laboratories has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Abbott Laboratories affect the company?

An increase in liabilities of Abbott Laboratories can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Abbott Laboratories affect the company?

A decrease in the liabilities of Abbott Laboratories can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Abbott Laboratories?

Some factors that can influence the liabilities of Abbott Laboratories include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Abbott Laboratories so important for investors?

The liabilities of Abbott Laboratories are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Abbott Laboratories take to modify the liabilities?

To change its liabilities, Abbott Laboratories can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Abbott Laboratories pay?

Over the past 12 months, Abbott Laboratories paid a dividend of 2.04 USD . This corresponds to a dividend yield of about 1.9 %. For the coming 12 months, Abbott Laboratories is expected to pay a dividend of 2.24 USD.

What is the dividend yield of Abbott Laboratories?

The current dividend yield of Abbott Laboratories is 1.9 %.

When does Abbott Laboratories pay dividends?

Abbott Laboratories pays a quarterly dividend. This is distributed in the months of August, November, March, May.

How secure is the dividend of Abbott Laboratories?

Abbott Laboratories paid dividends every year for the past 25 years.

What is the dividend of Abbott Laboratories?

For the upcoming 12 months, dividends amounting to 2.24 USD are expected. This corresponds to a dividend yield of 2.09 %.

In which sector is Abbott Laboratories located?

Abbott Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbott Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbott Laboratories from 5/15/2024 amounting to 0.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.

When did Abbott Laboratories pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Abbott Laboratories in the year 2023?

In the year 2023, Abbott Laboratories distributed 1.88 USD as dividends.

In which currency does Abbott Laboratories pay out the dividend?

The dividends of Abbott Laboratories are distributed in USD.